Ontvang nu dagelijks onze kooptips!
word abonnee
sluiten ✕
Terug naar discussie overzicht
Highlights: Revenues declined 8% to $875 million and adjusted EBITDA declined 20% to $220 million in Q2 2020 vs Q2 2019. Revenues increased 9% to $1.7 billion and adjusted EBITDA increased 2% to $413 million in H1 2020 vs H1 2019 OCI-produced volumes sold increased 6% to a record 3.3 million metric tons in Q2 2020 compared to Q2 2019 OCI also delivered record own-produced volumes of 6.0 million tons in H1 2020, up 26% compared to H1 2019. On a like-for-like basis, excluding Fertil, H1 2020 volumes improved 7% year-on-year Adjusted net loss of $20 million in Q2 2020 compared to adjusted net income of $37 million in Q2 2019 Free cash flow of $191 million before growth capex during the quarter Net debt $3.84 billion as of 30 June 2020, a reduction of $222 million compared to 31 December 2019 Fertiglobe has successfully negotiated final terms with lenders for a $385 million refinancing package1), which will crystallise interest savings of c.$9 million per annum OCI maintains a policy of not producing solid ammonium nitrate (AN), and has not done so since shutting down production of AN in 2008. With ever-increasing safety concerns surrounding AN, the product could be substituted by urea or other nitrates going forward Heike van de Kerkhof is nominated to OCI’s Board of Directors, bringing 30 years’ experience in the chemicals industry and a strong track record in sustainability COVID-19 has not caused any direct disruption to production or distribution to date Selling prices for urea and methanol have rebounded significantly since reaching trough levels during the second quarter, and the outlook for our end markets has recently improved
Statement from the Chief Executive Officer – Ahmed El-Hoshy: “We delivered resilient results supported by record volumes, despite selling prices reaching trough cycle levels during the quarter. This quarter our volumes increased 6% from the previous record second quarter last year. First half own-produced volumes increased 26% year over year, exceeding 6 million tons for the first time. Notwithstanding the low prices and the extraordinary circumstances as a result of the pandemic, we reduced net debt by $222 million so far this year. These results were achieved with an excellent safety record: the 12-month rolling recordable incident rate at the end of June was 0.23 incidents per 200,000 manhours, one of the lowest in our global industry. Operational excellence remains one of our main focus points going forward. The outlook for our end markets has become more positive in recent months and, given our low-cost position, OCI is well-positioned to benefit disproportionately vis-à-vis peers in this environment of improving selling prices. Global nitrogen fertilizer markets are looking positive for the remainder of this year and into 2021 on the back of healthy farm fundamentals, supported by strong demand from major importing countries, in particular India and Brazil, a recent strengthening of the outlook for the US, and increases in global corn demand. Urea prices have rebounded more than 30% since reaching a trough in the second quarter, but ammonia prices have lagged as a result of weak industrial demand. However, we have already seen a significant pick-up in diesel exhaust fluid sales in the US in July and August to record monthly levels, and have started to see recovery in demand of industrial ammonia and melamine. The outlook for our methanol end markets has also strengthened. Spot methanol prices have rebounded more than 50% since reaching trough levels towards the end of the second quarter. Demand from Methanol-to Olefins (MTO) plants in China has been rising and utilization rates now exceed 85% on the back of healthy economics. High inventories in the system are being cleared and high-cost methanol capacity has been shutting down. Global downstream demand continues to recuperate steadily, as fuel consumption is returning and a pick-up in construction and other industrial activity is driving increased demand for derivatives such as formaldehyde.
Our priority remains to optimize free cash flow generation and we remain committed to our financial policy to deleverage towards 2x through the cycle. We demonstrated healthy free cash flow conversion in the first half of this year despite the difficult macro environment, but timing to achieve our targets remains dependent on selling prices, as we continue to focus on operational and commercial excellence and volume growth. We maintain our forecast that we are on track to deliver robust volume growth in 2020. As we reach our run-rate production, we expect to benefit from a further step-up in volumes in 2021 compared to 2020. We expect this particularly in methanol, where we have finalized major turnarounds at OCI Beaumont in February and in the Netherlands in June. In addition, we continue to optimize our capital structure to identify further cost-effective refinancing opportunities as demonstrated by a $385 million refinancing at Fertiglobe. We are ahead of plan in generating commercial synergies at Fertiglobe, and we will now also achieve significant interest savings for the group. This debut financing for Fertiglobe will reset the capital structure and centralise some of the operating company debt at the Fertiglobe holding level. We are pleased that the facility has attracted strong interest from the capital markets and will achieve a low interest rate, reflecting the leading competitive position of Fertiglobe and its healthy balance sheet.“ Outlook Nitrogen The outlook for nitrogen fertilizers for the remainder of the year and into 2021 is looking considerably more favourable than a few months ago: Demand in several importing countries is expected to remain healthy, including South Asia, Latin America, East Africa and Australia The outlook for the US has strengthened recently as the downward revision of corn acreage by the USDA has reduced expected corn stocks and the outlook for corn demand has strengthened as ethanol markets recover. In addition, global demand for corn has increased driven by purchases from China We are anticipating a favourable fall application season in the US given the rapid pace of planting this spring and the maturity of the current corn crops, allowing for a potentially extended application window before winter Following a record quarter for our calcium ammonium nitrate (CAN) volumes in Q2, our order book in Europe is looking healthy. Going forward, we expect nitrate prices to be supported by healthy demand and room to catch up with increases in urea prices Higher domestic urea prices and demand in China, combined with temporary capacity shutdowns due to COVID-19 in China during the first half of 2020 limited the amount of urea available for export; full year Chinese exports are expected to be lower than in 2019 Industrial nitrogen markets have been weak in Q2 2020 as a result of GDP/industrial activity slowdown, but are showing signs of recovery: Global ammonia prices have lagged urea as a result of weak industrial demand, but should benefit from a recovery in industrial markets, with further support from curtailment of high-cost capacity and the recent increase in natural gas prices The fuel ethanol market in the US is recovering from trough conditions Demand for Diesel Exhaust Fluid (DEF) in the US has also increased significantly recently with the rebound of road traffic, and IFCo is reaching record shipments at increasing pace in Q3 so far Melamine demand in our core European markets is improving
Methanol US methanol spot prices have rebounded c.50% since reaching a bottom below $150 / ton in June Rising utilization rates of MTO plants in China on the back of healthy MTO economics versus naphtha crackers have been a key driver of a rebound in methanol demand The outlook for downstream demand has also improved, with fuel consumption picking up following the easing of lockdowns, and a gradual return of global industrial and construction activity; in the US and Europe we have seen month-to-month improvements in demand from the lows reached in the spring The idling of high cost methanol production capacity by competitors also helped tighten supply / demand balances in 2020 and supported pricing OCI is one of the lowest cost producers globally, and expected to benefit from the ramp-up of our methanol capacity as well as the normalization of production and improved onstream efficiency Gas Markets We expect to remain at the low end of the global cost curve. In addition, the recent increase in gas prices supports selling prices and benefits OCI as one of the lowest-cost and most efficient producers globally. A conference call for investors and analysts will be hosted on Thursday 27th August 2020 at 4:00 PM CET (3:00 PM GMT, 10:00 AM ET) by Ahmed El-Hoshy, Chief Executive Officer and Hassan Badrawi, Chief Financial Officer. Investors can access the call by dialing: Standard International: +44 (0) 20 3009 5710 United Kingdom FreeCall: 0800 376 7425 Netherlands LocalCall: +31 (0) 20 715 7366 United States FreeCall: 1 (866) 869 2321 Conference ID: 7283247 A conference call replay will be available until 27th September 2020. The replay access numbers are: Standard International: +44 (0) 333 300 9785 Netherlands: +31 (0) 20 713 2967 United States: 1 (866) 331-1332 Conference ID: 7283247
Positieve outlook en afbouw netto schuld gaan hem doen vandaag. Herstel naar 15-17 het komende kwartaal lijkt mij niet overdreven.
Goede cijfers, zal geen mega koersreactie komen maar dat de volumes omhoog gaan is het enige waar OCI invloed op heeft!
Ok ik ben geen expert maar dit ziet er wel goed uit en nog belangrijker; vooruitzichten op alle vlakken beter. Dit keer geen teleurstellende update. Lijkt erop dat we de komende tijd echt omhoog kunnen kijken.
Eerste indruk: - 2e kwartaal wat minder dan 1e - schuld wel weer verlaagd - positieve outlook (maar hoe hard is dat?)
Verlies minder dan ik had verwacht en fcf hoger dan ik had verwacht. Knap met de prijzen die op de borden stonden in Q2. Vooruitzichten positief, dat snap ik met de herstelde prijzen. Zo kan OCI zelf al steeds verder werken aan verbetering van waarde in het bedrijf nog zonder de verkoop van Methanol. Ongeacht de koersreactie is dit in ieder geval een bevestiging waarom ik in dit aandeel zit. Niet hot niet sexy maar degelijk en value en geen lucht.
Gewoon weer lekker naar beneden, jammer hoor
De familie mag vandaag ook weer beginnen te shoppen...
Kunstmestmaker OCI positiever ondanks gedaalde omzet Gepubliceerd op 27 augustus 2020 09:09 | Views: 247 OCI 09:00 12,50 +0,26 (+2,12%) AMSTERDAM (AFN) - OCI heeft in het tweede kwartaal meer kunstmest verkocht, maar door lage prijzen daalde de omzet van het bedrijf. Ook boekte de kunstmestproducent, die een notering aan de beurs in Amsterdam heeft, een verlies. Voor de rest van het jaar is OCI positiever gestemd. De onderneming heeft relatief weinig last gehad van de coronacrisis. Zo kon OCI het hele jaar gewoon aan grondstoffen komen en kon de productie ook overal nog doorgaan, zo gaf het aan. Eerder zei de kunstmestproducent al dat al zijn producten door overheden als essentieel waren aangemerkt. De omzet van OCI bedroeg 875,4 miljoen dollar, een daling van 8 procent ten opzichte van hetzelfde kwartaal een jaar eerder. Onder de streep bleef een verlies van 2,4 miljoen dollar over. OCI verkleinde in de periode ook zijn schuldenlast met 222 miljoen dollar tot 3,8 miljard dollar. Het bedrijf ziet de prijzen voor kunstmest weer stijgen en denkt daar de rest van het jaar van te kunnen profiteren, zeker gezien de relatief lage kosten die OCI heeft ten opzichte van de concurrentie. De onderneming heeft verder Heike van de Kerkhof genomineerd als niet-uitvoerend directeur, een functie die vergelijkbaar is met die van commissaris.
Op naar de 3KW cijfers in November :-) November 2020 Q3 Results
Gewoon teleurstellend Steeds een mooie outlook geven maar nooit waarmaken Dit gaat weer naar de 10
moneymaker_BX schreef op 27 augustus 2020 09:26 :
Gewoon teleurstellend
Steeds een mooie outlook geven maar nooit waarmaken
Dit gaat weer naar de 10
Ja vrees ik ook, loze beloftes
Wat een bullshit dit koersverloop. Marginaal verlies en goede outlook. 3e kwartaal is alweer 2/3 achter ons,..
moneymaker_BX schreef op 27 augustus 2020 09:26 :
Gewoon teleurstellend
Steeds een mooie outlook geven maar nooit waarmaken
Dit gaat weer naar de 10
Dit snap ik niet, ze geven een outlook, halen de outlook wat binnen hun eigen vermogen ligt, enkel de prijzen hebben ze zelf geen invloed op. Wat de spotprices zijn kan je zelf opzoeken, vandaar dat de koers hiernaar beweegt. Ik ben juist tevreden dat ze de hogere productie nu eindelijk behalen. Als de grondstofprijzen herstellen, dan zijn we winstgevender dan we hiervoor waren. Ik vind dit juist een koop/signaal en kijk er dan ook van op dat we naar het rood gaan. Ik vraag me dan af wat anderen hadden verwacht?!?
Er moeten (zijn al) vandaag nog veel turbo,s long gesloopt worden,blijft een gok aandeel,veel beloven en weinig geven.
ik ben net ingestapt 3000 op 12.04 ongeveer.. zie het ook als koopsignaal.
Aantal posts per pagina:
20
50
100
Direct naar Forum
-- Selecteer een forum --
Koffiekamer
Belastingzaken
Beleggingsfondsen
Beursspel
BioPharma
Daytraders
Garantieproducten
Opties
Technische Analyse
Technische Analyse Software
Vastgoed
Warrants
10 van Tak
4Energy Invest
Aalberts
AB InBev
Abionyx Pharma
Ablynx
ABN AMRO
ABO-Group
Acacia Pharma
Accell Group
Accentis
Accsys Technologies
ACCSYS TECHNOLOGIES PLC
Ackermans & van Haaren
ADMA Biologics
Adomos
AdUX
Adyen
Aedifica
Aegon
AFC Ajax
Affimed NV
ageas
Agfa-Gevaert
Ahold
Air France - KLM
Airspray
Akka Technologies
AkzoNobel
Alfen
Allfunds Group
Allfunds Group
Almunda Professionals (vh Novisource)
Alpha Pro Tech
Alphabet Inc.
Altice
Alumexx ((Voorheen Phelix (voorheen Inverko))
AM
Amarin Corporation
Amerikaanse aandelen
AMG
AMS
Amsterdam Commodities
AMT Holding
Anavex Life Sciences Corp
Antonov
Aperam
Apollo Alternative Assets
Apple
Arcadis
Arcelor Mittal
Archos
Arcona Property Fund
arGEN-X
Aroundtown SA
Arrowhead Research
Ascencio
ASIT biotech
ASMI
ASML
ASR Nederland
ATAI Life Sciences
Atenor Group
Athlon Group
Atrium European Real Estate
Auplata
Avantium
Axsome Therapeutics
Azelis Group
Azerion
B&S Group
Baan
Ballast Nedam
BALTA GROUP N.V.
BAM Groep
Banco de Sabadell
Banimmo A
Barco
Barrick Gold
BASF SE
Basic-Fit
Basilix
Batenburg Beheer
BE Semiconductor
Beaulieulaan
Befimmo
Bekaert
Belgische aandelen
Beluga
Beter Bed
Bever
Binck
Biocartis
Biophytis
Biosynex
Biotalys
Bitcoin en andere cryptocurrencies
bluebird bio
Blydenstijn-Willink
BMW
BNP Paribas S.A.
Boeing Company
Bols (Lucas Bols N.V.)
Bone Therapeutics
Borr Drilling
Boskalis
BP PLC
bpost
Brand Funding
Brederode
Brill
Bristol-Myers Squibb
Brunel
C/Tac
Campine
Canadese aandelen
Care Property Invest
Carmila
Carrefour
Cate, ten
CECONOMY
Celyad
CFD's
CFE
CGG
Chinese aandelen
Cibox Interactive
Citygroup
Claranova
CM.com
Co.Br.Ha.
Coca-Cola European Partners
Cofinimmo
Cognosec
Colruyt
Commerzbank
Compagnie des Alpes
Compagnie du Bois Sauvage
Connect Group
Continental AG
Corbion
Core Labs
Corporate Express
Corus
Crescent (voorheen Option)
Crown van Gelder
Crucell
CTP
Curetis
CV-meter
Cyber Security 1 AB
Cybergun
D'Ieteren
D.E Master Blenders 1753
Deceuninck
Delta Lloyd
DEME
Deutsche Cannabis
DEUTSCHE POST AG
Dexia
DGB Group
DIA
Diegem Kennedy
Distri-Land Certificate
DNC
Dockwise
DPA Flex Group
Draka Holding
DSC2
DSM
Duitse aandelen
Dutch Star Companies ONE
Duurzaam Beleggen
DVRG
Ease2pay
Ebusco
Eckert-Ziegler
Econocom Group
Econosto
Edelmetalen
Ekopak
Elastic N.V.
Elia
Endemol
Energie
Energiekontor
Engie
Envipco
Erasmus Beursspel
Eriks
Esperite (voorheen Cryo Save)
EUR/USD
Eurobio
Eurocastle
Eurocommercial Properties
Euronav
Euronext
Euronext
Euronext.liffe Optiecompetitie
Europcar Mobility Group
Europlasma
EVC
EVS Broadcast Equipment
Exact
Exmar
Exor
Facebook
Fagron
Fastned
Fingerprint Cards AB
First Solar Inc
FlatexDeGiro
Floridienne
Flow Traders
Fluxys Belgium D
FNG (voorheen DICO International)
Fondsmanager Gezocht
ForFarmers
Fountain
Frans Maas
Franse aandelen
FuelCell Energy
Fugro
Futures
FX, Forex, foreign exchange market, valutamarkt
Galapagos
Gamma
Gaussin
GBL
Gemalto
General Electric
Genfit
Genmab
GeoJunxion
Getronics
Gilead Sciences
Gimv
Global Graphics
Goud
GrandVision
Great Panther Mining
Greenyard
Grolsch
Grondstoffen
Grontmij
Guru
Hagemeyer
HAL
Hamon Groep
Hedge funds: Haaien of helden?
Heijmans
Heineken
Hello Fresh
HES Beheer
Hitt
Holland Colours
Homburg Invest
Home Invest Belgium
Hoop Effektenbank, v.d.
Hunter Douglas
Hydratec Industries (v/h Nyloplast)
HyGear (NPEX effectenbeurs)
HYLORIS
Hypotheken
IBA
ICT Automatisering
Iep Invest (voorheen Punch International)
Ierse aandelen
IEX Group
IEX.nl Sparen
IMCD
Immo Moury
Immobel
Imtech
ING Groep
Innoconcepts
InPost
Insmed Incorporated (INSM)
IntegraGen
Intel
Intertrust
Intervest Offices & Warehouses
Intrasense
InVivo Therapeutics Holdings Corp (NVIV)
Isotis
JDE PEET'S
Jensen-Group
Jetix Europe
Johnson & Johnson
Just Eat Takeaway
Kardan
Kas Bank
KBC Ancora
KBC Groep
Kendrion
Keyware Technologies
Kiadis Pharma
Kinepolis Group
KKO International
Klépierre
KPN
KPNQwest
KUKA AG
La Jolla Pharmaceutical
Lavide Holding (voorheen Qurius)
LBC
LBI International
Leasinvest
Logica
Lotus Bakeries
Macintosh Retail Group
Majorel
Marel
Mastrad
Materialise NV
McGregor
MDxHealth
Mediq
Melexis
Merus Labs International
Merus NV
Microsoft
Miko
Mithra Pharmaceuticals
Montea
Moolen, van der
Mopoli
Morefield Group
Mota-Engil Africa
MotorK
Moury Construct
MTY Holdings (voorheen Alanheri)
Nationale Bank van België
Nationale Nederlanden
NBZ
Nedap
Nedfield
Nedschroef
Nedsense Enterpr
Nel ASA
Neoen SA
Neopost
Neovacs
NEPI Rockcastle
Netflix
New Sources Energy
Neways Electronics
NewTree
NexTech AR Solutions
NIBC
Nieuwe Steen Investments
Nintendo
Nokia
Nokia OYJ
Nokia Oyj
Novacyt
NOVO-NORDISK AS
NPEX
NR21
Numico
Nutreco
Nvidia
NWE Nederlandse AM Hypotheek Bank
NX Filtration
NXP Semiconductors NV
Nyrstar
Nyxoah
Océ
OCI
Octoplus
Oil States International
Onconova Therapeutics
Ontex
Onward Medical
Onxeo SA
OpenTV
OpGen
Opinies - Tilburg Trading Club
Opportunty Investment Management
Orange Belgium
Oranjewoud
Ordina Beheer
Oud ForFarmers
Oxurion (vh ThromboGenics)
P&O Nedlloyd
PAVmed
Payton Planar Magnetics
Perpetuals, Steepeners
Pershing Square Holdings Ltd
Personalized Nursing Services
Pfizer
Pharco
Pharming
Pharnext
Philips
Picanol
Pieris Pharmaceuticals
Plug Power
Politiek
Porceleyne Fles
Portugese aandelen
PostNL
Priority Telecom
Prologis Euro Prop
ProQR Therapeutics
PROSIEBENSAT.1 MEDIA SE
Prosus
Proximus
Qrf
Qualcomm
Quest For Growth
Rabobank Certificaat
Randstad
Range Beleggen
Recticel
Reed Elsevier
Reesink
Refresco Gerber
Reibel
Relief therapeutics
Renewi
Rente en valuta
Resilux
Retail Estates
RoodMicrotec
Roularta Media
Royal Bank Of Scotland
Royal Dutch Shell
RTL Group
RTL Group
S&P 500
Samas Groep
Sapec
SBM Offshore
Scandinavische (Noorse, Zweedse, Deense, Finse) aandelen
Schuitema
Seagull
Sequana Medical
Shurgard
Siemens Gamesa
Sif Holding
Signify
Simac
Sioen Industries
Sipef
Sligro Food Group
SMA Solar technology
Smartphoto Group
Smit Internationale
Snowworld
SNS Fundcoach Beleggingsfondsen Competitie
SNS Reaal
SNS Small & Midcap Competitie
Sofina
Softimat
Solocal Group
Solvac
Solvay
Sopheon
Spadel
Sparen voor later
Spectra7 Microsystems
Spotify
Spyker N.V.
Stellantis
Stellantis
Stern
Stork
Sucraf A en B
Sunrun
Super de Boer
SVK (Scheerders van Kerchove)
Syensqo
Systeem Trading
Taiwan Semiconductor Manufacturing Company (TSMC)
Technicolor
Tele Atlas
Telegraaf Media
Telenet Groep Holding
Tencent Holdings Ltd
Tesla Motors Inc.
Tessenderlo Group
Tetragon Financial Group
Teva Pharmaceutical Industries
Texaf
Theon International
TherapeuticsMD
Thunderbird Resorts
TIE
Tigenix
Tikkurila
TINC
TITAN CEMENT INTERNATIONAL
TKH Group
TMC
TNT Express
TomTom
Transocean
Trigano
Tubize
Turbo's
Twilio
UCB
Umicore
Unibail-Rodamco
Unifiedpost
Unilever
Unilever
uniQure
Unit 4 Agresso
Univar
Universal Music Group
USG People
Vallourec
Value8
Value8 Cum Pref
Van de Velde
Van Lanschot
Vastned
Vastned Retail Belgium
Vedior
VendexKBB
VEON
Vermogensbeheer
Versatel
VESTAS WIND SYSTEMS
VGP
Via Net.Works
Viohalco
Vivendi
Vivoryon Therapeutics
VNU
VolkerWessels
Volkswagen
Volta Finance
Vonovia
Vopak
Warehouses
Wave Life Sciences Ltd
Wavin
WDP
Wegener
Weibo Corp
Wereldhave
Wereldhave Belgium
Wessanen
What's Cooking
Wolters Kluwer
X-FAB
Xebec
Xeikon
Xior
Yatra Capital Limited
Zalando
Zenitel
Zénobe Gramme
Ziggo
Zilver - Silver World Spot (USD)